http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103328477-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c229187936ebd346db01e595b7b2ab7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08
filingDate 2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d36b29d61805d92f856662191909089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c45dc3be4bad1e5a383abcd04396655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9bcf6ddb16e83670b964f5bcf23254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59be5d50a7a5dc30c7e61febfb87ee59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55c6138b308d5fb700bb1b90d9100f43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23b60abbd7a6d913994826a5d760563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d46b26d8c2a7b7f693088295afbe415
publicationDate 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103328477-A
titleOfInvention Pharmaceutical compositions containing pyridone derivatives
abstract A pyridone derivative and pharmaceutically acceptable salts, isomers, solvates, and hydrates thereof, and a preventive or therapeutic pharmaceutical composition for cognitive impairment, the composition comprising The pyridone derivative or its pharmaceutically acceptable salt, isomer, solvate or hydrate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109293507-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109293507-A
priorityDate 2011-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010056622-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468284641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466751022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466751021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466442062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465267589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468010445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466442065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466442063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163638951

Total number of triples: 39.